News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Naveen Jain’s microbiome and diagnostics startup Viome is raising more cash
Seattle-area startup Viome Life Sciences secured $67 million in funding, increasing its total capital raise to over $125 million. The company sells kits that determine

Report: Washington life sciences companies landed over $5B last year
Washington life science companies brought in about $5.1 billion in total investment last year, according to Life Science Washington’s first-annual 2021 Washington State Investor Report.

Life sciences entrepreneurs offer advice on launching and building startups
In a recent panel hosted by the University of Washington, five entrepreneurs shared their advice on what it takes to launch a life science company

UW ranks No. 26 for best universities in the world, study finds
A new study from Times Higher Education ranks the University of Washington as the 26th best university in the world. The University of Oxford (U.K.)

Fred Hutchinson Cancer Center receives ‘transformative’ $710.5M gift from the Bezos family
The Fred Hutchinson Cancer Center received a $710.5 million philanthropic gift from Amazon founder Jeff Bezos’ parents, Jackie and Mike Bezos. Fred Hutch President and

Seattle company NanoString Technologies snags space in Bothell
Research device company NanoString Technologies has leased a 28,000-square-foot location in Bothell. The new facility will house instrument manufacturing, engineering, logistics, and support operations and

The 50 Best Places to Live in the U.S. | 2022—2023
Kirkland, Washington has been ranked the third-best city in the U.S. to live in 2022, according to Money’s annual report. The rankings were based on

Promising data from large Alzheimer’s study bodes well for this Seattle startup
New findings from a Biogen and Eisai clinical trial reveal that the companies’ Alzheimer’s therapy, lecanemab, can slow cognitive decline. The news is promising for

Seagen and LAVA Therapeutics Ink $700M+ Deal for EGFR Solid Tumor Platform
Bothell-based biotech Seagen is partnering on a licensing deal with LAVA Therapeutics for its solid tumor technology. LAVA-1223, a preclinical medication that uses LAVA’s patented

Alpine Immune Sciences raising $100M in public offering
Seattle-based biotech Alpine Immune Sciences is seeking $100 million in an underwritten public offering. The company of 130 employees has grown 65 percent over the

Institute for Systems Biology awarded $13M to study administering cancer drugs in succession
Seattle’s Institute for Systems Biology has been awarded $13 million by the National Cancer Institute. The money will be used to lead a collaborative cancer

Allen Institute lands over $173M for brain research
The National Institute of Health has awarded the Allen Institute $173 million in funding for a variety of brain research initiatives. The nonprofit will get
